Misplaced Pages

Talk:Biosafety level

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.

This is an old revision of this page, as edited by MiszaBot I (talk | contribs) at 02:55, 22 August 2011 (Archiving 2 thread(s) (older than 14d) to Talk:Biosafety level/Archive 1.). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Revision as of 02:55, 22 August 2011 by MiszaBot I (talk | contribs) (Archiving 2 thread(s) (older than 14d) to Talk:Biosafety level/Archive 1.)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)
This is the talk page for discussing improvements to the Biosafety level article.
This is not a forum for general discussion of the article's subject.
Article policies
Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL
Archives: 1Auto-archiving period: 14 days 
WikiProject iconMedicine C‑class Low‑importance
WikiProject iconThis article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Misplaced Pages talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine
CThis article has been rated as C-class on Misplaced Pages's content assessment scale.
LowThis article has been rated as Low-importance on the project's importance scale.

Missing Level 3/4 Facility

On the table, there is an entry to say a Level 4 facility is being built in the United Kingdom, but not where, nor who the owner of the building/land is currently. Most likely to be the DSTL or even QinetiQ, although the latter is highly unlikey. Perhaps a research university such as Oxford, Cambridge, Birmingham or perhaps Imperial College?

Hendra virus is NOT a BSL-3 pathogen

It is a BSL-4 pathogen. —Preceding unsigned comment added by 158.111.5.34 (talk) 21:55, 16 December 2010 (UTC)

Private BSL-3 facilities abound

Having worked and consulted in the DC area, RTP, Chicago, and at corporate sites around the eastern half of the US, I don't see any way to reasonably assemble a complete list of BSL-3 facilities. None of the ones I've worked at except USAMRIID are on this list; BSL-3 facilities are simply too common. Many vaccine manufacturing and testing facilities exist that can handle the pathogens requiring BSL-3, and most of them are not publicly advertised. The key point for BSL-3 is that treatment exists; if the treatment is derived from the living pathogen, industry will need this facility. While there isn't a West nile, Anthrax, SARS, or yellow fever testing facility on every corner, they are not uncommon enough to have the scarcity noted.

152.14.43.30 (talk) 16:51, 20 April 2011 (UTC) TWM

REDACTED

My apologies, I was wrong. Nevermind! Salvidrim (talk) 16:51, 21 August 2011 (UTC)

Categories: